Validation of TriAGE+ for predicting stroke risk in patients with dizziness
External Validation of the TriAGE+ Score for Predicting Cerebrovascular Disease Risk in Patients Presenting With Dizziness in the Emergency Department
This study is testing a new tool called TriAGE+ to see if it can help doctors figure out which patients with dizziness are at risk for a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 841 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Marmara University Pendik Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06641050 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the TriAGE+ score, a tool developed to assess the risk of stroke in patients presenting with dizziness in emergency departments. Given that posterior circulation strokes are often misdiagnosed, the study will evaluate the safety, applicability, and reliability of the TriAGE+ score in predicting cerebrovascular diseases. The research will involve patients who present with dizziness and will collect data to determine the effectiveness of the score in identifying those at risk for serious neurological events. The findings could enhance diagnostic accuracy and improve patient outcomes in emergency settings.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who present to the emergency department with dizziness as their primary complaint.
Not a fit: Patients whose primary symptom is syncope or presyncope, or those with dizziness due to major hemodynamic events, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of stroke risk in patients presenting with dizziness, potentially reducing misdiagnosis and improving patient outcomes.
How similar studies have performed: While the TriAGE+ score is a novel approach, similar studies have highlighted the challenges of diagnosing posterior circulation strokes, indicating a need for improved risk assessment tools.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with dizziness who presented to the emergency department * Patients who provide informed consent, or legal guardians providing consent for patients unable to do so. Exclusion Criteria: * Patients whose primary symptom is syncope or presyncope, or who present with dizziness due to hemodynamic compromise from gastrointestinal bleeding or other major events. * Patients under the influence of alcohol or substances. * Pregnant patients. * Patients previously included in the study. * Patients who refuse medical treatment or withdraw consent. * Patients with incomplete data necessary for the study.
Where this trial is running
Istanbul
- Marmara University Pendik Training and Research Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Yeşim Acem, MD
- Email: yesimgezer96@gmail.com
- Phone: +905343648832
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.